Q4 2025 Earnings Call March 19, 2026 4:30 PM EDTCompany ParticipantsDavid Krempa - Chief Business OfficerSean Brynjelsen ...

Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026; Type A meeting with FDA expected to occur within 30 ...

Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestinal cancers, announces its ...

Petela, R. and Biel, J. (2026) Radiation from Proxima Centauri Reaching Its Planet Proxima b. International Journal of ...

Gold Royalty Corp. is pleased to announce the filing of its operating and financial results for year ended 31, 2025. All amounts are expressed . David Garofalo, Chairman and CEO of Gold Royalty, ...

Plug Power (NASDAQ:PLUG) shares are up 5% in today’s session, trading around $2.26 as of midday Monday. The move extends a broader recovery that has the stock up 36% over the past year. The catalyst ...

Microsoft drops due to concerns over Azure's momentum and market share shifts, especially versus Google Cloud. Check out why MSFT stock is a sell.

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart ...

Ipsa cites rising abuse and constituency workloads as reasons for above-inflation increase of 5% from April The basic annual salary of MPs will soon rise to £110,000, the expenses watchdog has said, ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai"), a human-centered global leading research-based ...

Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFO Tel: +44 (0)29 2048 0180 The Company's lead development programs include eRapa, under development for Familial Adenomatous Polyposis and ...

VANCOUVER, BC, March 18, 2026 /PRNewswire/ - Gold Royalty Corp. ("Gold Royalty" or the "Company") (NYSE American: GROY) is pleased to announce the filing of its operating ...